[{"Assets_0_Q1_USD":296600000.0,"CommonStockSharesOutstanding_0_Q1_shares":65020320.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-39902000.0,"NetIncomeLoss_1_Q1_USD":-39672000.0,"StockholdersEquity_0_Q1_USD":43159000.0,"Ticker":"DVAX","CIK":"1029142","name":"DYNAVAX TECHNOLOGIES CORP","OfficialName":"Dynavax Technologies Corporation Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1279198792.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]